
A new study from the Massachusetts Institute of Technology, Harvard, Virginia Tech and the University of Connecticut has shown that …

The FDA has approved Takeda’s Alunbrig (brigatinib) for adult patients with anaplastic lymphoma kinase-positive (ALK+) metastatic non-small cell lung cancer …

UK pharma giant GlaxoSmithKline has pledged to pay a cash bonus of £1,500 to staff continuing to work during the …

The World Health Organization has announced it will stop a global study into the effectiveness of hydroxychloroquine in COVID-19 patients, …

“The COVID-19 pandemic has made the development of a safe, effective, and deployable vaccine a critical global priority”, said researchers …

A trial investigating the effectiveness of hydroxychloroquine against COVID-19 has begun in the UK. The first participants will be enrolled …

About a quarter of the world’s population are at higher risk of catching the COVID-19 coronavirus due to a lack …

Scientists at the Lawrence Berkeley National Laboratory are launching a project to apply machine learning methods to map the severity, …

AstraZeneca is attempting to deliver one billion doses of coronavirus vaccine by September, which is currently being developed in collaboration …

Trump continues to play a key role in the unfolding COVID-19 pandemic, with the US currently coping with the largest …

A study emerging from the Massachusetts Institute of Technology (MIT) and published in the Harvard Data Science Review has detailed strategies …

A new study published in The Lancet has called on the global health community to establish guidelines to develop and …

Doctors could use nanotechnology to assess the morality risk from COVID-19, according to research from Michigan State University. Morteza Mahmoudi, …

People suffering type 1 diabetes are far more likely to die of coronavirus than those with type 2, according to …

Biotech firm Moderna has unveiled interim data from its Phase 1 trial of mRNA-1273, its vaccine against SARS-CoV-2, the virus …

AstraZeneca has provided an update on the partnership it forged with the University of Oxford in late April to push …

The US has threatened to permanently cut off funding to the World Health Organization if they do not take proposed …

The Trump administration will sign a $354 million deal with the generics company Phlow Corp to help produce medicines and …

President Donald Trump told reporters last night that he is taking the drug hydroxychloroquine to ward off COVID-19, despite US …

Notorious incarcerated ex-pharma CEO Martin Shkreli has his request rejected to be released from prison in order to research a …